The living library : an indigenous community in the Peruvian Amazon is combating climate change, deforestation, and loss of traditional knowledge by preserving their plants in the... by Lockwood, Devi(Devi Kailasa)

Get full text

Capturing Value in Pharmaceutical Distribution Strategies by Matz, Lauren, Ogbuefi, Irene

“…From this study, it is evident that considering the market structure and pharmaceutical regulations of individual countries helps pharmaceutical companies tailor supply chain strategies to each country’s context to maximize patient satisfaction, resource mobilization and cost optimization.…”
Get full text

The evaluation of system-wide financial incentives in pipeline decisions in the pharmaceutical and biotechnology industry : the paradox of R&D spend Vs. new drug approvals by Swarna, Kailash, 1963-

Get full text

Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. by Cipriani, A, Hawton, K, Stockton, S, Geddes, J

“…Medline, Embase, CINAHL, PsycINFO, CENTRAL, web based clinical trial registries, major textbooks, authors of important papers and other experts in the discipline, and websites of pharmaceutical companies that manufacture lithium or the comparator drugs (up to January 2013). …”

Pharmacovigilance analysis of the Vigibase on antidepressants-related withdrawal syndrome in adults and adolescents by C. Gastaldon, G. Schoretsanitis, E. Arzenton, E. Raschi, D. Papola, G. Ostuzzi, U. Moretti, E. Seifritz, J. M. Kane, G. Trifirò, C. Barbui

“…Trifirò Grant / Research support from: he was the scientific director of a Master program on pharmacovigilance, pharmacoepidemiology and real-world evidence which has received non-conditional grant from various pharmaceutical companies; he coordinated a pharmacoepidemiology team at the University of Messina until Oct 2020, which has received funding for conducting observational studies from various pharmaceutical companies (Boehringer Ingelheim, Daichii Sankyo, PTC Pharmaceuticals). …”
Get full text

A study of perceptions and exposure of drug promotional literature among clinicians in a teaching hospital by Sushil Sharma, Neha Akhoon, Htet Wai Moe, Deepak R Nair, Venkat Shashidhar

“…Background: Drug promotional literature (DPL) forms a major marketing technique of pharmaceutical companies for propagating information regarding a drug. …”
Get full text

Randomized controlled trials of HIV/AIDS prevention and treatment in Africa: results from the Cochrane HIV/AIDS Specialized Register. by Babalwa Zani, Elizabeth D Pienaar, Joy Oliver, Nandi Siegfried

“…Trials were co-funded by different agencies with most of the funding obtained from USA governmental and non-governmental agencies. Nineteen pharmaceutical companies provided partial funding to 15 RCTs and African agencies co-funded 17 RCTs. …”
Get full text

Bibliometric analysis of rheumatic immune related adverse events associated with immune checkpoint inhibitors by Li Zeng, Gang Ma, Gang Ma, Kai Chen, Qiao Zhou, Qiao Zhou

“…Apart from government funding, pharmaceutical companies such as Bristol Myers Squibb and Merck Company also play a significant role in drug development and research. …”
Get full text

Loss, Doubt, and Betrayal: Strands of Vaccination Skepticism on Three Facebook Pages Involved in the Controversy Over Human Papillomavirus (HPV) Vaccination by Torben Esbo Agergaard, Kristian H. Nielsen

“…The “they” were all those in favor of HPV vaccination, particularly the health authorities, pharmaceutical companies, and the Danish Cancer Society. Based on the study findings, it can be concluded that HPV vaccination skepticism is mediated through discourses that are personal, epistemological, social, or political, and value-laden in nature. …”
Get full text

Active search about latex in injectable drugs for patient’s safety in medical therapy by Roberta G. PEIXE, Maria C. SODRÉ, Beatriz B. OLIVEIRA, Luana P. GONÇALVES, Ian G. HALM, José C. CRUZ, Ana P. ANTUNES, Rodrigo T. AMANCIO

“…Only written information from pharmaceutical companies were considered. Results: Among 161 medicines used in the hospital packaged in vials with rubber stoppers, antibiotics, and electrolytes bags, 123 (76.4%) medicine-related responses were received, covering 540 (82.2%) different presentations. …”
Get full text

Assessment of Efficacy and Quality of Two Albendazole Brands Commonly Used against Soil-Transmitted Helminth Infections in School Children in Jimma Town, Ethiopia. by Sileshi Belew, Mestawet Getachew, Sultan Suleman, Tesfaye Mohammed, Habetewold Deti, Matthias D'Hondt, Evelien Wynendaele, Zeleke Mekonnen, Jozef Vercruysse, Luc Duchateau, Bart De Spiegeleer, Bruno Levecke

“…Although anthelminthic drugs which are used for MDA are supplied by two pharmaceutical companies through donation, there is a wide range of brands available on local markets for which the efficacy against STHs and quality remain poorly explored. …”
Get full text

Association with severe and treatment-resistant depression among patients with inflammatory joint disease. Nationwide nested case-control study in Swedish registers by P. Brenner, J. Askling, P. Stang, L. Brandt, D. Hägg, J. Reutfors

“…Disclosure PB, JA, DH, LB, and JR are affiliated to or employees at The Unit for Clinical Epidemiology, Karolinska Institutet, which receives grants from several entities (pharmaceutical companies, regulatory authorities, contract research organizations) for the per …”
Get full text

Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania [version 1; peer review... by Elizabeth Pisani, Adina-Loredana Nistor, Amalia Hasnida, Koray Parmaksiz, Jingying Xu, Maarten Oliver Kok

“…In response, legitimate, profit-driven pharmaceutical companies protect their margins by cutting costs, or withdrawing from less profitable markets, while distributors engage in arbitrage. …”
Get full text

The Significance of Alliance Networks in Research and Development of Digital Health Products for Diabetes: Observational Study by Satoru Kikuchi, Kota Kodama, Shintaro Sengoku

“…In the innovation ecosystem, new alliance networks are formed not only by medical device companies and pharmaceutical companies, but also by information and communications technology companies and start-ups. …”
Get full text

Sharing knowledge for policy action in low- and middle-income countries: A literature review of managed entry agreements by Hector E. Castro, Tanya Malpica-Llanos, Ruth Musila, Niranjan Konduri, Ana Amaris, Jennifer Sullivan, Colin Gilmartin

“…Managed entry agreements (MEAs)—a type of formal institutional arrangement between pharmaceutical companies and payers for sharing the risk with respect to the introduction of new pharmaceutical technologies—may expand access to new pharmaceutical technologies for non-communicable diseases (NCDs). …”
Get full text

Using provocative design to foster electronic informed consent innovation by Evelien De Sutter, Stef Verreydt, Koen Yskout, David Geerts, Pascal Borry, An Outtier, Marc Ferrante, Corinne Vandermeulen, Nele Vanmechelen, Bart Van der Schueren, Isabelle Huys

“…Nevertheless, this study indicates a general willingness of participants to share personal data with physicians and pharmaceutical companies on an international level, and to receive requests for new research studies via an eIC system. …”
Get full text

Academic dependency: the influence of the prevailing international biomedical research agenda on Argentina’s CONICET by Mercedes García Carrillo, Federico Testoni, Marc-André Gagnon, Cecilia Rikap, Matías Blaustein

“…Background: The prevailing health and biomedical sciences (HBMS) research agenda, not only determined by leading academic institutions but also by large pharmaceutical companies, has been shown to prioritize the exploration of novel pharmacological interventions over the study of the socio-environmental factors influencing illness onset and progression. …”
Get full text

Prediction of potential inhibitors of SARS-CoV-2 using 3D-QSAR, molecular docking modeling and ADMET properties by Ayoub Khaldan, Soukaina Bouamrane, Fatima En-Nahli, Reda El-mernissi, Khalil El khatabi, Rachid Hmamouchi, Hamid Maghat, Mohammed Aziz Ajana, Abdelouahid Sbai, Mohammed Bouachrine, Tahar Lakhlifi

“…For this reason, COVID-19 has become one of the most lethal viruses which the modern world has ever witnessed although some established pharmaceutical companies allege that they have come up with a remedy for COVID-19. …”
Get full text

Fair inclusion of pregnant women in clinical trials: an integrated scientific and ethical approach by Rieke van der Graaf, Indira S. E. van der Zande, Hester M. den Ruijter, Martijn A. Oudijk, Johannes J. M. van Delden, Katrien Oude Rengerink, Rolf H. H. Groenwold

“…In addition to researchers and research ethics committees, scientific advisory councils, funders, drug regulatory agencies, pharmaceutical companies, journal editors and others have a joint responsibility to further develop the evidence base for drug use in pregnant women.…”
Get full text

ERANET JTC 2011: Submission and Activation of an International Academic Translational Project in Advanced Breast Cancer. Experience From the ET-FES Study by Manuela Monti, Tom Degenhardt, Etienne Brain, Rachel Wuerstlein, Alessandra Argusti, Matteo Puntoni, Gian Andrea Rollandi, Davide Corradengo, Luca Boni, Harun Ilhan, Oriana Nanni, Javier Cortes, Alejandro Piris-Gimenez, Arnoldo Piccardo, Massimiliano Iacozzi, Federica Matteucci, Valentina Di Iorio, Jean Louis Alberini, Carolien Schröder, Nadia Harbeck, Alessandra Gennari

“…Accrual was stopped on 22nd January 2021 due to an 18F FES shortage as the primary reason but also for having exceeded the project deadlines with consequent exhaustion of the funds allocated for the project.Conclusions: Pharmaceutical companies might be reluctant to fund research projects aimed at treatment individualization if the approval for a wider indication has already been achieved. …”
Get full text